Followers | 0 |
Posts | 3,161 |
Boards Moderated | 0 |
Alias Born | 02/25/2019 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PAOG Its rare we have this kind of heads up before the PR comes out.
I definitely like getting in at this level. $PAOG
Hearing some positive developments are in play for $PAOG
$PAOG needs to wake up here
Going to be a great week. $PAOG
$PAOG so many developments yet to be unveiled. Quite sure we get an update soon.
Should hit the Breakout Board once it gets updated. $PAOG
$RBII licenses Cannophen to $PAOG as exclusive manufacturer.
$PAOG smells like we could have news here soon.
$PAOG looks like we good get a big push.
$RBII the three pronged business model really brings a strategic advantage here.
$PAOG is going to be the smash hit MJ play of the summer. Bit upside coming IMHO.
Great developments here. $PAOG
Cannophen launch is a big tipping point for $PAOG
$PAOG CBD only Cannophen should be hitting the market soon.
$RBII expecting some more big reveals here soon.
$RBII with a solid route for putting a dent in the Opioid crisis via Cannophen CBD only
$PAOG will be the big Cannabis runner of 2019.
Karl Riedel seems like seriously busy bee. He has major marketing chops and it seems we could see the fruit of that very soon. $PAOG
First comes volume then comes price. $PAOG
I believe we could get a PR here soon, that would bring this back to life. $PAOG
$RBII green solid here, support has also moved up.
Up 8,11% green and running here we go $RBII
Up 30.00% $PAOG more green coming right up.
First comes volume then comes price. $PAOG
NICE UP 30.00% this morning $PAOG
$RBII debut run back in June tested at a full 25mg CBD per capsule, so we anticipate similar results for this batch of our CBD only variant.
$RBII The first production run is done and initial samples are being sent to the lab for testing.
Initial results seem to indicate that CBD could change the face of opioid addiction treatment, succeeding where other conventional therapies have had mixed results. $RBII
Cannophen features an alternative delivery system for rapid reception of the full metabolic benefits of beneficial compounds derived from the hemp plant. $RBII
Cannophen oral capsules and vape cartridges have been developed using strict standards set forward by the pharmaceutical compounding industry.
Cannophen is Rising Biosciences flagship product. $RBII
Good morning $RBII players
$PAOG CBD only Cannaphen really changes the ballgame.
$PAOG Through its subsidiaries and investment holdings, the company focuses on the growing, processing, and transportation of premium medical cannabis products for the treatment of chronic and terminal patients. PAO Group’s holdings include RSB Management, Inc.
$PAOG is a publicly traded holdings company in America dedicated to alternative patient care treatments, including the proper use of medical cannabis.
$PAOG also debuted some pre-production samples of Cannophen vape cartridge at the Cannabis Cup.
$PAOG plans to announce a release for the 1:1 vape cartridges, which will also feature premium THC distillate and full-spectrum CBD distillate along with organic terpenes, in the near future.
Cannophen™ vape cartridges are currently in pre-production.
This year’s Michigan Cannabis Cup boasted a record attendance, with the event sold out on both Saturday and Sunday to an estimated 50,000 attendees and approximately 260 vendors.